Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 7, Number 6—December 2001
Research

The Serologic Response to Cryptosporidium in HIV-Infected Persons: Implications for Epidemiologic Research

Joseph N.S. Eisenberg*Comments to Author , Jeffrey W. Priest†, Patrick J. Lammie†, and John M. Colford*
Author affiliations: *University of California, Berkeley, California, USA;; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 1

Summary of antibody responses for the 11 cases and their respective controls

Cases Controls Cases Controls Cases Controls Cases Controls
Mean 2,784c 414 2,117c -17 1,594 85 1,531 5
Max 12,224 973 11,247 157 9,264 217 9,239 69
Min 102 178 -866 -144 36 41 -5 47
Median 1,334d 329 433d -32 140 56 71d 1
S.D. 3,560 237 3,531 84 2,880 53 2,884 36
N 11 22 11 22 11 22 11 22

aIgG response after the date of clinical cryptosporidiosis diagnosis.
bDifference in IgG response between a sample taken before and after date of cryptosporidiosis diagnosis.
cCase value is significantly different from control value (p<0.05).
dCase value is significantly different from control value (p<0.01).
IgG = immunoglobulin G; TX17 = Triton antigen; SD = standard deviation.

Main Article

Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external